Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Scott Biggins MD, MAS

Scott W. Biggins MD, MAS

Chief of Hepatology and Director of Liver Care Line, Division of Gastroenterology, University of Washington, Seattle, Washington; Director, Center for Liver Investigation Fostering discovEry (C-LIFE), University of Washington, Seattle, Washington

Dr. Scott Biggins is Chief of Hepatology, Director of the Liver Care Line for UW Medicine, and Director of the Center for Liver Investigation Fostering Discovery (C-LIFE) at the University of Washington. Dr. Biggins is a nationally recognized clinician and researcher in the field of Hepatology. Dr. Biggins' clinical interests are the risk reduction and management of complications of end-stage liver disease, and the clinical evaluation and care of liver transplant candidates and recipients. He has been recognized as a fellow of American Society of Transplantation (FAST), American Association for the Study of Liver Diseases (FAASLD), and American Gastroenterological Association (AGAF). He is Chair of the AASLD Special Interest Group (SIG) for Portal Hypertension and Vice Chair of the OPTN/UNOS Liver & Intestine Committee.

Dr. Biggins’ research focuses on complications of portal hypertension, improving recipient and donor selection for liver transplantation and revising organ allocation algorithms in order to maximize patient outcomes. He has received research funding from the American Liver Foundation, National Institutes of Health and the Agency for Healthcare Research and Quality. He has over 100 publications in peer-reviewed journals including the New England Journal of Medicine, Gastroenterology, Hepatology, and Liver Transplantation.


Dr. Biggins has no relevant disclosures.